o-(4-ethoxybutyl)berbamine has been researched along with fluorouracil in 1 studies
| Studies (o-(4-ethoxybutyl)berbamine) | Trials (o-(4-ethoxybutyl)berbamine) | Recent Studies (post-2010) (o-(4-ethoxybutyl)berbamine) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | o-(4-ethoxybutyl)berbamine (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Liu, J; Qi, S; Wang, T; Zhang, J; Zhu, H | 1 |
1 other study(ies) available for o-(4-ethoxybutyl)berbamine and fluorouracil
| Article | Year |
|---|---|
The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
Topics: Alkaloids; Animals; Antimetabolites, Antineoplastic; Benzylisoquinolines; Calmodulin; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; Inhibitory Concentration 50; Liver Neoplasms, Experimental; Mice; Neoplasm Transplantation; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |